Stockreport
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash [Yahoo! Finance]
Last hologic, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
The adjustments include charges and benefits related to the amortization of acquired intangible assets, restructuring charges, facility closure and consolidation charges and many others. The company's GAAP EPS was 79 cents in the quarter, which decreased 9.2% year over year. Revenues totaled $1.05 billion in the quarter, up 2.5% year over year (1.3% at the constant exchange rate or CER). The top line fell short of the Zacks Consensus Estimate by 2.14%. On a regional basis,U.S. revenues increased 2% to $773.5 million. International revenues amounted to $274.3 million, up 4% year over year (down 1% at CER). Following the earnings announcement, HOLX shares fell 0.1% in yesterday's after-hours session. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Diagnostics revenues fell 1.3% year over year (2.7% at CER) to $464.4 million in the quarter. Within this, Molecular Diagnostics revenues decreased 3.5%, due to lower sales o
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | HOLX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
HOLX alerts
HOLX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOLX alerts
High impacting Hologic, Inc. news events
Weekly update
A roundup of the hottest topics
HOLX
NEWS
NEWS
- Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio[Business Wire]
- Hologic (NASDAQ:HOLX) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.[MarketBeat]
- Hologic Announces Financial Results for First Quarter of Fiscal 2026[Business Wire]
- Analysts consider potential Qiagen deal amid reported strategic review [Yahoo! Finance][Yahoo! Finance]
- Hologic, Inc. (HOLX): A Bear Case Theory [Yahoo! Finance][Yahoo! Finance]
- More
HOLX
SEC Filings
SEC Filings
- 2/12/26 - Form 4
- 2/6/26 - Form 8-K
- 2/3/26 - Form 4/A
- HOLX's page on the SEC website
- More